Intravenous Iron Drugs Usage in the Treatment of Iron Deficiency Anemia in Patients with Chronic Kidney Disease
Journal Title: Нирки - Year 2016, Vol 3, Issue 17
Abstract
The article reviews the current recommendations on treating anemia in chronic kidney disease. It is emphasized on the priority appointment of iron preparations. The comparative characteristic of iron supplementation efficacy in chronic renal diseas is presented. Advantages of ferric carboxymaltose are discussed.
Authors and Affiliations
D. D. Ivanov, Ya. A. Dombrowski
Keywords
Related Articles
- EP ID EP208318
- DOI 10.22141/2307-1257.3.17.2016.76454
- Views 94
- Downloads 0
Renoprotection and its association with eGFR and renal functional reserve
Renoprotection is a system of measures for primarily pharmacological control, contributing to the continued preservation of renal function. When choosing renoprotection tactics, it is necessary to consider not only the e...
Hyperuricemia — an independent factor for the progression of chronic kidney disease
Objective of the research — to evaluate the efficacy of combined hypouricemic therapy in patients with hyperuricemia, urate nephropathy on the background of concomitant pathology (type 2 diabetes mellitus, hypertension)...
2016 European Guidelines on cardiovascular disease prevention in clinical practice
.
Acute Glomerulonephritis: Clinical and Pathologic Features (Case Report)
Clinical observation demonstrates the case of acute postinfectious glomerulonephritis with its histopathological features with the preexisting injury of renal tubules — cystic kidney disease of undefined type. The patien...
Features of renal involvement in systemic connective tissue diseases
Connective tissue diseases (CTDs) are a heterogeneous group of disorders that have certain clinical presentations and a disturbed immunoregulation, leading to autoantibody production. Subclinical or overt renal manifesta...